CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 29, 2008--Alkermes, Inc.
(NASDAQ: ALKS) announced today that its corporate presentation will be
webcast live by Merrill Lynch on Tuesday, February 5, 2008 at 4:00
p.m. EST. The presentation will be webcast from The Grand Hyatt Hotel
in New York and may be accessed under the investor relation's tab at
www.alkermes.com. The presentation will be archived for 14 days.
Alkermes, Inc. is a biotechnology company that uses proprietary
technologies and know-how to create innovative medicines designed to
yield better therapeutic outcomes for patients with serious disease.
Alkermes manufactures RISPERDAL(R) CONSTA(R), marketed by
Janssen-Cilag (Janssen, L.P.), a wholly owned division of Johnson &
Johnson, and developed and manufactures VIVITROL(R), marketed in the
U.S. primarily by Cephalon, Inc. The company's pipeline includes
extended-release injectable, pulmonary and oral products for the
treatment of prevalent, chronic diseases, such as central nervous
system disorders, addiction and diabetes. Alkermes is headquartered in
Cambridge, Massachusetts, with research and manufacturing facilities
in Massachusetts and Ohio.
CONTACT: Alkermes, Inc.
Debra Koufos, 617-583-6220
Associate, Corporate Communications
SOURCE: Alkermes, Inc.